The products are being recalled for having excessively high flow rates that could deliver medications too quickly and cause illness, seizures, heart rhythms and death. Symbios is working to have all affected products returned.
More Articles on Anesthesia:
Can ASCs Profit From Anesthesia? Points on OIG Guidance
ASC Anesthesia Best Practices
4 Ways in Which Anesthesia Departments Can Contribute to an ASC’s Success
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
